Status:
COMPLETED
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
Lead Sponsor:
University Health Network, Toronto
Conditions:
Cancer of the Prostate
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to see if an intervention of antioxidants(vitamin E, selenium and lycopene) can change (reduce) prostate tumor size and alter certain markers that can affect tumor growth ...
Eligibility Criteria
Inclusion
- Diagnosis of a Gleason score \> or = to 7 adenocarcinoma of the prostate
- At least 30% of one core involved
- Radical prostatectomy planned
- Willingness to discontinue use of supplements at least 4 weeks prior to study intervention (for subjects using vitamin E, selenium or lycopene at time of consent)
- ability and willingness to consume study intervention for 6 - 8 weeks prior to radical prostatectomy.
Exclusion
- Previous treatment for prostate cancer
- Current use of finasteride or dutasteride
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00844792
Start Date
October 1 2008
End Date
December 1 2013
Last Update
October 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network, Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9